Expression of activated-leukocyte cell adhesion molecule in ovarian serous carcinoma and its significance
10.3760/cma.j.issn.1006-9801.2012.11.011
- VernacularTitle:活化白细胞黏附分子在卵巢浆液性肿瘤中的表达及其意义
- Author:
Jianlong QIU
;
Haigang XU
- Publication Type:Journal Article
- Keywords:
Ovarian neoplasms;
Activated-leukocyte cell adhesion molecule;
Immunohistochemistry;
CD166
- From:
Cancer Research and Clinic
2012;(11):755-757
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the expression of activated leukocyte cell adhesion molecule (ALCAM/CD166) in serous ovarian tumors and its significance.Methods The expression level of CD166 protein,estrogen receptor,progestogen receptor were detected by immunohistochemical staining in 56 cases of malignant tumors,30 cases of borderline tumors and 10 cases of benign tumors,the relationship was investigated between the expression of CD166 and clinicopathologic information and its correlation with the expression of estrogen receptor (ER) and progestogen receptor (PR).Results The positive rates of CD166 protein in malignant,borderline and benign epithelial ovarian tumors were 87.5 ％ (49/56),56.7 ％ (17/30) and 10.0 ％ (1/10) respectively,there were significant differences (x2 =7.463,31.054,10.563,all P ＜ 0.01).There were also significant differences in positive rates of CD166 protein among different clinical stages,pathologic grades and lymph node metastasis of epithelial ovarian tumors (x2 =41.205,Z =-4.663,Z =-2.981,all P ＜ 0.01).There was a negative correlation between the expression of CD166 protein and the leves of ER and PR (x2 =23.36,21.441,both P ＜ 0.05).Conclusion CD166 takes part in development and progression of serous ovarian carcinoma.The expression of CD166 increase significantly in ovarian serous carcinoma.
